Michael Swartzburg

About Michael Swartzburg

Chief Financial Officer with 25+ years of executive experience leading financial strategy, operational scale, and commercial execution in biotechnology, pharmaceuticals, and healthcare technology companies.Honored by L.A. Times B2B Publishing as a 2024 CFO Forum & Leadership Awards Honoree (Midsize Public Company) and recognized as a Top CFO by the Orange County Business Journal (2024) and Los Angeles Business Journal (2023).Specializes in value creation through commercialization, capital markets strategy, and transaction execution, with a career spanning $3+ billion in M&A, IPOs, and follow-on financings. Extensive hands-on experience across SEC reporting, earnings management, pre-IPO readiness, manufacturing finance, Sarbanes-Oxley compliance, and enterprise-wide FP & A.Big Four–trained CPA (Ernst & Young LLP) with a pragmatic, execution-oriented approach to scaling growth companies and navigating public-company complexity.CERTIFICATION: Certified Public Accountant, State of California (active)

Experience

1. Chief Financial Officer

   SMSbiotech

   Mar 2026 — Present · Carlsbad, CA, US

   SMSbiotech is a San Diego-based biotech company that discovered and named a novel human stem cell and is utilizing it to advance the field of regenerative medicine using an off-the-shelf cell therapy and other approaches.

Education

• University of Phoenix

  Master of Business Administration (MBA)

• California State University, Northridge

  Bachelor's degree, Business Administration, Accounting

Skills

• Accounting
• Management
• Mergers & Acquisitions
• Financial Analysis
• Finance
• Financial Reporting
• Sarbanes-Oxley Act
• Forecasting
• Managerial Finance
• Mergers
• Sec Filings
• Start-Ups
• Auditing
• Account Management